Institutional investors purchased a net $10.3 million shares of KERX during the quarter ended June 2017 and now own 66.96% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONSONANCE CAPITAL MANAGEMENT LP Bought 7.0 Million shares of Keryx Biopharmaceuticals ...
POINT72 ASSET MANAGEMENT LP Bought 1.5 Million shares of Keryx Biopharmaceuticals ...